1. Hirota M., Ohmuraya M., and H. Baba. /Genetic background of pancreatitis.// Postgrad. J. Med, 2006 82: 775-778
2. Johnson C. D., Lempinen M., Imrie C. W., P. Puolakkainen, E. Kemppainen, R Carter. and C. McKay. / Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis // British Journal of Surgery 2004; 91: 1027-1033
3. Geert W. Schmid-Schönbein. / The autodigestion hypothesis: Proteolytic receptor cleavage in rheological and cardiovascular cell dysfunction1// Biorheology -1 (2017) 1-13
4. Chen P., Yuan Y., Wang S., Zhan L., Xu J. / Serum matrix metalloproteinase 9 as a marker for the assessment of severe acute pancreatitis // Tohoku J Exp Med. 2006 Mar;208(3):261-6
5. Guo J.1, Xue P., Yang X.N, Liu X.B, Huang W., Xia Q. / Serum matrix metalloproteinase-9 is an early marker of pancreatic necrosis in patients with severe acute pancretis // Hepatogastroenterology. 2012 Jul-Aug;59(117):1594-8
6. Johnson C. D., Lempinen M., Imrie C. W., P. Puolakkainen, E. Kemppainen, R Carter. and C. McKay. / Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis // British Journal of Surgery 2004; 91: 1027-1033
7. Elin Hadler-Olsen, Bodil Fadnes, Ingebrigt Sylte, Lars Uhlin-Hansen, Jan-Olof Winberg. / Regulation of matrix metalloproteinase activity in health and disease // FEBS Journal Volume 278, Issue 1, pages 28-45, January 2011
8. Bu C. H., Pourmotabbed T / Mechanism of Ca2+ dependent activity of human neutrophil gelatinase // J BiolChem 271-14308-14315. 1996